95
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery

, , , , , , & show all
Pages 1297-1311 | Published online: 06 Mar 2018

References

  • BakhtiarASayyadMRosliRMaruyamaAChowdhuryEHIntracellular delivery of potential therapeutic genes: prospects in cancer gene therapyCurr Gene Ther201414424725725039616
  • JoergerACFershtARThe p53 pathway: origins, inactivation in cancer, and emerging therapeutic approachesAnnu Rev Biochem20168537540427145840
  • YueXZhaoYXuYZhengMFengZHuWMutant p53 in cancer: accumulation, gain-of-function, and therapyJ Mol Biol2017429111595160628390900
  • MantovaniFWalerychDSalGDTargeting mutant p53 in cancer: a long road to precision therapyFEBS J2017284683785027808469
  • Freed-PastorWAPrivesCMutant p53: one name, many proteinsGenes Dev201226121268128622713868
  • MullerPAVousdenKHMutant p53 in cancer: new functions and therapeutic opportunitiesCancer Cell201425330431724651012
  • KarmakarABrattonSMDervishiEEthylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cellsInt J Nanomedicine201161045105521720516
  • LiZZhangLLiQInduction of apoptosis in cancer cells through N-acetyl-l-leucine-modified polyethylenimine-mediated p53 gene deliveryColloids Surf B Interfaces2015135630638
  • ZhangJWuDXingZN-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cellsColloids Surf B Interfaces20151295462
  • CaiXJinRWangJBioreducible fluorinated peptide dendrimers capable of circumventing various physiological barriers for highly efficient and safe gene deliveryACS Appl Mater Interfaces2016895821583226887907
  • ChenSRongLLeiQA surface charge-switchable and folate modified system for codelivery of proapoptosis peptide and p53 plasmid in cancer therapyBiomaterials20167714916326599622
  • DavoodiPSrinivasanMPWangCHSynthesis of intracellular reduction-sensitive amphiphilic polyethyleneimine and poly(ε-caprolactone) graft copolymer for on-demand release of doxorubicin and p53 plasmid DNAActa Biomater201639799327154500
  • DuanSYuBGaoCYuanWMaJXuFJA facile strategy to prepare hyperbranched hydroxyl-rich polycations for effective gene therapyACS Appl Mater Interfaces2016843293342934227726331
  • MengTWuJYiHA spermine conjugated stearic acid-g-chitosan oligosaccharide polymer with different types of amino groups for efficient p53 gene therapyColloids Surf B Interfaces2016145695705
  • YinHKanastyRLEltoukhyAAVegasAJDorkinJRAndersonDGNon-viral vectors for gene-based therapyNat Rev Genet201415854155525022906
  • GilliesERFrechetJMJDendrimers and dendritic polymers in drug deliveryDrug Discov Today2005101354315676297
  • LeeCCMacKayJAFréchetJMSzokaFCDesigning dendrimers for biological applicationsNat Biotechnol200523121517152616333296
  • TomaliaDABirth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistryProg Polym Sci200530294324
  • YinZLiuNMaMWangLHaoYZhangXA novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimersInt J Nanomedicine201274625463522942644
  • Labieniec-WatalaMWatalaCPAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applicationsJ Pharm Sci2015104121425363074
  • MataiISachdevAGopinathPSelf-assembled hybrids of fluorescent carbon dots and PAMAM dendrimers for epirubicin delivery and intracellular imagingACS Appl Mater Interfaces2015721114231143525946165
  • WangFWangYWangHShaoNChenYChengYSynergistic effect of amino acids modified on dendrimer surface in gene deliveryBiomaterials201435339187919825112938
  • WangFHuKChengYStructure-activity relationship of dendrimers engineered with twenty common amino acids in gene deliveryActa Biomater2016299410226525113
  • FuFWuYZhuJWenSShenMShiXMultifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacerACS Appl Mater Interfaces2014618164161642525185074
  • WangYLiLShaoNTriazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcomaActa Biomater20151711512425595474
  • ChenWLiuYLiangXHuangYLiQChondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a deliveryActa Biomater20175723825028511876
  • WangMLiuHLiLChengYA fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratiosNat Commun20145305324407172
  • WangMChengYThe effect of fluorination on the transfection efficacy of surface-engineered dendrimersBiomaterials201435246603661324818889
  • ShaoNDaiTLiuYChengYA supramolecular approach to improve the gene transfection efficacy of dendrimersChem Commun2015514797419743
  • WangHWeiHHuangQNucleobase-modified dendrimers as nonviral vectors for efficient and low cytotoxic gene deliveryColloids Surf B Biointerfaces20151361148115526613860
  • HanHYangJWangYNucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancerBiomater Sci20175112268227528976503
  • WuDWangCYangJImproving the intracellular drug concentration in lung cancer treatment through the codelivery of doxorubicin and miR-519c mediated by porous PLGA microparticleMol Pharm201613113925393327684197
  • JulienOWellsJACaspases and their substratesCell Death Differ20172481380138928498362